Neuros Medical, Evolent Health, Osprey Medical
August 14, 2017
Source: medicaldevice-network
531
Neuros Medical Inc has secured $20m in a series AA Financing round led by US Venture Partners.
The US-based company plans to use the funds to progress its IDE clinical study.
Evolent Health Inc has announced a public offering of seven million class A common stock shares priced at $24.1 each to raise $175m.
"Osprey plans to use the stocks to invest in research and development (R&D) and for marketing of its products."
Located in the US, Evolent plans to use funds to purchase class A common shares.
US-based company Osprey Medical Inc has announced the private placement of 27 million common stock shares priced at A$0.4 ($0.32) each to raise A$22.18m ($17.61m).
Osprey plans to use the stocks to invest in research and development (R&D) and for marketing of its products.
By Ddu
Copyright©2024 Ddu. All rights reserved.
Read more on
- Things to Know before Buying Newborn Baby Incubators March 31, 2022
- Highly Resistant Food Poisoning Bug Responds to Antibiotics September 6, 2018
- Smartphone Based Diagnosis to Identify Mosquitoes Transmitting Infection September 5, 2018
- 3 Natural Plant Extracts Manufacturers on Drugdu.com September 4, 2018
- Shenzhen Chuanggan – Health Assessment Facility Supplier September 4, 2018
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
